569 related articles for article (PubMed ID: 7531368)
1. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
[TBL] [Abstract][Full Text] [Related]
2. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Lund B; Hansen OP; Hansen HH; Hansen M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
[TBL] [Abstract][Full Text] [Related]
4. European experience with ifosfamide in non-small cell lung cancer.
Drings P
Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645
[TBL] [Abstract][Full Text] [Related]
5. [Cisplatin etoposide versus cisplatin/etoposide/ifosfamide combination chemotherapy in small-cell lung cancer: a multicenter randomized controlled study. Hokkaido Study Group of Treatment for Small-Cell Lung Cancer].
Miyamoto H; Kawakami Y; Arimoto T; Asakawa M; Suzuki A; Fujikane T; Onodera S; Nakabayashi T; Yasuda S; Shimizu T
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1127-34. PubMed ID: 1647149
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
Shepherd FA; Goss PE; Latreille J; Stewart D; Logan D; Evans WK; Maroun J; Warner E
Semin Oncol; 1990 Apr; 17(2 Suppl 4):19-23. PubMed ID: 2159185
[TBL] [Abstract][Full Text] [Related]
7. High-dose etoposide and autologous bone marrow transplantation as intensification treatment in small cell lung cancer: a pilot study.
Marangolo M; Rosti G; Amadori D; Leoni M; Ardizzone A; Fiorentini G; Cruciani G; Tienghi A; Ravaioli A; Sebastiani L
Bone Marrow Transplant; 1989 Jul; 4(4):405-8. PubMed ID: 2550104
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
Shepherd FA; Evans WK; MacCormick R; Feld R; Yau JC
Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571
[TBL] [Abstract][Full Text] [Related]
9. Limited small cell lung cancer: possible prognostic impact of initial chemotherapy doses.
Arriagada R; de The H; Le Chevalier T; Thomas F; Ruffie P; de Cremoux H; Martin M; Duroux P; Dewar J; Sancho-Garnier H
Bull Cancer; 1989; 76(6):604-15. PubMed ID: 2550102
[TBL] [Abstract][Full Text] [Related]
10. [Dose intensity chemotherapy in lung cancer].
Takada M; Fukuoka M; Negoro S; Masuda N; Kudo S
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2005-12. PubMed ID: 1699498
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer.
Yamada K; Saijo N; Kojima A; Ohe Y; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Goya T; Kondou H
Jpn J Clin Oncol; 1991 Feb; 21(1):39-45. PubMed ID: 1648633
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report.
Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
Semin Oncol; 1992 Dec; 19(6 Suppl 12):58-63. PubMed ID: 1336623
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.
Bronchud M; Scarffe JH; Thatcher N; Crowther D; Souza LM; Alton NK; Testa NG; Dexter TM
Behring Inst Mitt; 1988 Aug; (83):327-9. PubMed ID: 2467655
[TBL] [Abstract][Full Text] [Related]
14. Combination of chemotherapy and radiotherapy in limited small cell lung carcinoma: results of alternating schedule in 109 patients.
Le Chevalier T; Arriagada R; de Thé H; De Cremoux H; Martin M; Baldeyrou P; Ruffié P; Benna F; Cerrina ML; Sancho-Garnier H
NCI Monogr; 1988; (6):335-8. PubMed ID: 2832769
[TBL] [Abstract][Full Text] [Related]
15. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
Irino S; Fujita J; Yamaji Y; Futami H; Hashimoto Y; Bungo M; Iuchi Y; Kamei M; Nakamura H; Hata Y
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy with cisplatin, adriamycin, etoposide and ifosfamide in microcytic lung carcinoma].
García Gómez R; García Arroyo R; Meana García A; Martínez del Prado P; González del Val R; Pérez Manga G
Med Clin (Barc); 1992 Sep; 99(8):289-93. PubMed ID: 1333558
[TBL] [Abstract][Full Text] [Related]
17. [A pilot study of etoposide, split-dose cisplatin and THP in small cell lung cancer].
Matsui Y; Satake N; Kusume K; Kado M; Ohshima S; Yamamoto Y; Ishida H; Matsubara Y; Ikeda S
Gan To Kagaku Ryoho; 1991 Dec; 18(15):2567-72. PubMed ID: 1660701
[TBL] [Abstract][Full Text] [Related]
18. [Chemo-radiotherapy combination in small cell bronchial carcinomas. Limitations and results in 109 patients treated with an alternating protocol].
Le Chevalier T; Arriagada R; Baldeyrou P; de Cremoux H; Ruffié P; Martin M; Cerrina ML; de Thé G; Sancho-Garnier H; Hayat M
Bull Cancer; 1987; 74(5):559-64. PubMed ID: 2825857
[TBL] [Abstract][Full Text] [Related]
19. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
Honda R; Nishiwaki Y; Hino M; Hayashibe A; Yano H; Kitaya T; Matsuyama T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2965-9. PubMed ID: 3021067
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
Motzer RJ; Bajorin DF; Vlamis V; Weisen S; Bosl GJ
Semin Oncol; 1992 Dec; 19(6 Suppl 12):8-11. PubMed ID: 1336624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
